Risultati della Ricerca - Temozolomide and irinotecan regimen as liquid biopsy-guided non-cross reistant sequential adjuvant treatment of patients with MGMT methylated, micro satellite stable colorectal cancer failing to achieve seroreversion after a standard adjuvant strategy (Studio ERAZE-TMZ)
Temozolomide and irinotecan regimen as liquid biopsy-guided non-cross reistant sequential adjuvant treatment of patients with MGMT methylated, micro satellite stable colorectal cancer failing to achieve seroreversion after a standard adjuvant strategy (Studio ERAZE-TMZ)
Temozolomide and irinotecan regimen as liquid biopsy-guided non-cross reistant sequential adjuvant treatment of patients with MGMT methylated, micro satellite stable colorectal cancer failing to achieve seroreversion after a standard adjuvant strategy (Studio ERAZE-TMZ)
Collaborazione Professionale
Menu
Tipologia: Collaborazione Professionale
Stato: In corso
Data Emissione: 10/03/2023
Data Scadenza: 17/03/2023
Allegati
- prot DI 5152011.pdf - pdf 880KB
Responsabile della pubblicazione: Redazione Lavora con noi
Ultimo aggiornamento: 10/03/2023
